Related Experiment Videos

Meconium enhances the release of nitric oxide in human airway epithelial cells

Amir M Khan1, Kevin P Lally, Okan Elidemir

  • 1Department of Pediatrics, Division of Neonatology, University of Texas-Houston Medical School, Houston, TX 77030, USA.

Biology of the Neonate
|February 15, 2002
PubMed

Insights

Meconium aspiration syndrome (MAS) involves airway epithelial cells releasing nitric oxide when exposed to meconium. This study shows meconium enhances nitric oxide production, suggesting a role for epithelial cells in MAS pathogenesis.

Area of Science:

  • Pulmonary Medicine
  • Neonatology
  • Cell Biology

Background:

  • Meconium aspiration syndrome (MAS) is a significant cause of infant morbidity and mortality.
  • The precise pathogenesis of MAS and the role of epithelial-derived metabolites remain poorly understood.

Purpose of the Study:

  • To investigate the effect of meconium exposure on nitric oxide production in human airway epithelial cells.
  • To explore the potential role of airway epithelial cells and their metabolic products in MAS.

Main Methods:

  • A549 human airway epithelial cells were incubated with varying concentrations of meconium.
  • Nitrite production in cell supernatants was measured at different time points.
  • The impact of dexamethasone, L-NAME, and indomethacin on nitrite release was assessed.

Main Results:

  • Meconium exposure significantly increased nitrite release from A549 cells.
  • Dexamethasone, L-NAME, and indomethacin demonstrated inhibitory effects on meconium-induced nitrite release.
  • These findings indicate that meconium stimulates nitric oxide production in airway epithelial cells.

Conclusions:

  • Airway epithelial cells enhance nitric oxide production upon meconium exposure.
  • Epithelial-derived metabolites, such as nitric oxide, may contribute to the pathogenesis of MAS.
  • Further research into these cellular mechanisms could inform MAS treatment strategies.

Related Concept Videos